DSM
About DSM
DSM is a global purpose-led, science-based company specializing in Nutrition, Health & Sustainable Living. Our purpose is to create brighter lives for all. We achieve it by using all the scientific and innovation power at our disposal to tackle some of the world’s greatest challenges - creating value for customers, shareholders, our people, and society-at-large.
46 articles about DSM
-
Aerie Pharmaceuticals, Inc. and DSM Biomedical, Inc. Expand Collaboration Agreement Focused on Novel Drug Delivery Technology in Ophthalmology
8/1/2018
Promising Technology Platform to Potentially Deliver Therapies to Treat a Broad Spectrum of Ophthalmic Diseases.
-
Medtec China 2018 Scale Will Grow by 10% to Feed the Rapidly Growing Needs of the Medical Device Industry in China
3/6/2018
This year the scale of Medtec China 2018 will grow by 10%, reaching a new height since 2015.
-
DSM Pharmaceutical Products And Tunitas Therapeutics Sign Agreement To Develop Lead Allergy Therapeutic
12/3/2013
-
DSM Pharmaceutical Products Celebrates Opening of New cGMP Facility for Biopharmaceutical Manufacturing in Brisbane, Australia
10/30/2013
-
DSM Pharmaceutical Products and Opthea Sign Agreement to Manufacture Opthea's Lead Product for Eye Disease
10/30/2013
-
DSM Pharmaceutical Products and Sanquin Blood Supply Foundation Sign Agreement for Commercial Manufacture of Factor IX - Antibody
10/24/2013
-
Manja Bouman Ph.D. Appointed President and Business Unit Director of Biopharm Businesses at DSM Pharmaceutical Products
10/22/2013
-
Veronika Zuegel, Ph.D., New Vice President of Human Resources & Communications at DSM Pharmaceutical Products
7/16/2013
-
DSM Pharmaceutical Products Announces June Opening of New cGMP Biopharmaceutical Manufacturing Operation in Brisbane, Australia
4/22/2013
-
DSM Pharmaceutical Products and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
4/22/2013
-
DSM Pharmaceutical Products to Supply Cancer Drug for Eisai Inc.
3/5/2013
-
DSM Pharmaceutical Products and Chemtrix Sign Collaboration Agreement in Continuous Flow Chemistry
2/19/2013
-
Almac Group and DSM Pharmaceutical Products Collaboration Agreement in Biocatalysis Continues With Success
2/19/2013
-
DSM Pharmaceutical Products Announces Biologics Development and Manufacturing Agreement for Australian Facility
10/24/2012
-
DSM Pharmaceutical Products and Almac Group Sign Collaboration Agreement in Biocatalysis
10/8/2012
-
DSM Pharmaceutical Products Announces Patent Grants for Proprietary XD(R) Biomanufacturing Technology
6/19/2012
-
DSM Pharmaceutical Products Announces Major Commercial Agreement for Services Using Its XD® Technology
6/18/2012
-
Laura L. Parks, Ph.D., Appointed President and Business Unit Director of Finished Dosage Business at DSM Pharmaceutical Products
5/24/2012
-
DSM Pharmaceutical Products Receives Best Contract Manufacturing Organization Award from Biopharma Asia
4/3/2012
-
DSM Pharmaceutical Products and Agennix AG Sign New Contract for Commercial Manufacture of Talactoferrin
3/13/2012